When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKCA - Regeneron's evinacumab successful in late-stage study in inherited type of high cholesterol
Akcea Therapeutics Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN) announces the successful outcome of a Phase 3 clinical trial, ELIPSE HoFH, evaluating evinacumab in patients with an inherited form of severely elevated levels of "bad" (LDL-C) cholesterol called homozygous familial hypercholesterolemia (HoFH).
More news on: Regeneron Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Amgen Inc., Healthcare stocks news,